Adebrelimab Combined With AG Regimen in Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Clinical trial NCT06916975 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06916975
Sponsor: Jin Xu
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Non-resectable Pancreatic Cancer Metastatic

Start date: 2025-04-15
Primary completion: 2027-12-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.